ViewRay Inc. (VRAY)

2.53
0.08 3.30
NASDAQ : Health Technology
Prev Close 2.45
Open 2.42
Day Low/High 2.41 / 2.54
52 Wk Low/High 2.12 / 10.02
Volume 61.84K
Avg Volume 2.31M
Exchange NASDAQ
Shares Outstanding 98.48M
Market Cap 227.49M
EPS -1.00
P/E Ratio N/A
Div & Yield N.A. (N.A)

Latest News

LEAD PLAINTIFF DEADLINE ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 In ViewRay, Inc. To Contact The Firm

LEAD PLAINTIFF DEADLINE ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 In ViewRay, Inc. To Contact The Firm

NEW YORK, Sept. 18, 2019 /PRNewswire/ -- Faruqi & Faruqi, LLP, a leading national securities law firm, reminds investors in ViewRay, Inc.

Scott Scott Attorneys At Law LLP Alerts Investors To Securities Class Action Against ViewRay, Inc. (VRAY)

Scott Scott Attorneys At Law LLP Alerts Investors To Securities Class Action Against ViewRay, Inc. (VRAY)

NEW YORK, Sept. 17, 2019 /PRNewswire/ --  Scott+Scott Attorneys at Law LLP ("Scott+Scott"), a national securities and consumer rights litigation firm, is notifying investors that a class action lawsuit has been filed against ViewRay, Inc.

VRAY CLASS ACTION ALERT: Bernstein Liebhard LLP Announces The Filing Of A Securities Class Action Lawsuit Against ViewRay Inc

VRAY CLASS ACTION ALERT: Bernstein Liebhard LLP Announces The Filing Of A Securities Class Action Lawsuit Against ViewRay Inc

NEW YORK, Sept. 17, 2019 /PRNewswire/ -- Bernstein Liebhard LLP, a nationally acclaimed investor rights law firm, announces that a securities class action has been filed on behalf of investors that purchased or acquired the securities of ViewRay Inc.

Federman & Sherwood Announces Filing Of Securities Class Action Lawsuit Against ViewRay, Inc.

Federman & Sherwood Announces Filing Of Securities Class Action Lawsuit Against ViewRay, Inc.

Federman & Sherwood announces that on September 13, 2019, a class action lawsuit was filed in the United States District Court for the Northern District of Ohio against ViewRay, Inc.

EQUITY ALERT: Rosen Law Firm Announces Filing Of Securities Class Action Lawsuit Against ViewRay, Inc. - VRAY

EQUITY ALERT: Rosen Law Firm Announces Filing Of Securities Class Action Lawsuit Against ViewRay, Inc. - VRAY

Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of the securities of ViewRay, Inc.

Penn State Health Enters Into Master Purchase Agreement With ViewRay For MRIdian® Systems

Penn State Health Enters Into Master Purchase Agreement With ViewRay For MRIdian® Systems

Immediate order of one system with ability to purchase an additional three systems

ViewRay Announces Collaboration With Stanford Health Care

ViewRay Announces Collaboration With Stanford Health Care

Stanford Health Care to Acquire a ViewRay MRIdian System

Leading Radiation Oncology Meeting To Feature Unique Capabilities And Compelling Patient Outcomes With ViewRay's MRIdian

Leading Radiation Oncology Meeting To Feature Unique Capabilities And Compelling Patient Outcomes With ViewRay's MRIdian

Clinicians from 17 Hospitals Worldwide to Present Clinical Experience with MRIdian MRI-Guided Radiation Therapy at ASTRO

ViewRay (VRAY) Alert: Johnson Fistel Launches Investigation Into ViewRay, Inc.; Investors Encouraged To Contact Firm

ViewRay (VRAY) Alert: Johnson Fistel Launches Investigation Into ViewRay, Inc.; Investors Encouraged To Contact Firm

SAN DIEGO, Sept. 4, 2019 /PRNewswire/ -- Shareholder Rights Law Firm Johnson Fistel, LLP is investigating potential claims against ViewRay, Inc.

ViewRay To Host Investor Meeting At 2019 ASTRO Annual Meeting In Chicago

ViewRay To Host Investor Meeting At 2019 ASTRO Annual Meeting In Chicago

CLEVELAND, Aug. 27, 2019 /PRNewswire/ -- ViewRay, Inc.

First Week Of November 15th Options Trading For ViewRay (VRAY)

First Week Of November 15th Options Trading For ViewRay (VRAY)

Investors in ViewRay Inc saw new options become available this week, for the November 15th expiration. One of the key inputs that goes into the price an option buyer is willing to pay, is the time value, so with 86 days until expiration the newly available contracts represent a possible opportunity for sellers of puts or calls to achieve a higher premium than would be available for the contracts with a closer expiration.

ViewRay Announces Results Of The First Prospective Clinical Trial On MR-guided Radiation Treatment For Prostate Cancer Without Implanted Markers

ViewRay Announces Results Of The First Prospective Clinical Trial On MR-guided Radiation Treatment For Prostate Cancer Without Implanted Markers

Study Shows Low Incidence of Early Toxicity Using Stereotactic Body Radiation Therapy (SBRT) While Eliminating Potential Complications and Costs Associated with Implanted Markers

ViewRay® To Participate In Upcoming Investor Conferences

ViewRay® To Participate In Upcoming Investor Conferences

CLEVELAND, Aug. 15, 2019 /PRNewswire/ -- ViewRay, Inc.

ViewRay Reports Second Quarter 2019 Results

ViewRay Reports Second Quarter 2019 Results

CLEVELAND, Aug. 8, 2019 /PRNewswire/ -- ViewRay, Inc.

RSI Alert: ViewRay (VRAY) Now Oversold

RSI Alert: ViewRay (VRAY) Now Oversold

Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index, or RSI, which measures momentum on a scale of zero to 100.

ViewRay Announces Conference Call And Webcast Of Second Quarter 2019 Financial Results To Be Held After Market On August 8, 2019

ViewRay Announces Conference Call And Webcast Of Second Quarter 2019 Financial Results To Be Held After Market On August 8, 2019

CLEVELAND, July 18, 2019 /PRNewswire/ -- ViewRay, Inc. (Nasdaq: VRAY) announced today details relating to the release of its second quarter 2019 financial results.

ViewRay Announces Appointment Of Dr. Gail Wilensky To Its Board Of Directors

ViewRay Announces Appointment Of Dr. Gail Wilensky To Its Board Of Directors

CLEVELAND, July 16, 2019 /PRNewswire/ -- ViewRay, Inc. (Nasdaq: VRAY) announced the appointment of Dr.

Noteworthy Thursday Option Activity: VRAY, TITN, MRK

Noteworthy Thursday Option Activity: VRAY, TITN, MRK

Looking at options trading activity among components of the Russell 3000 index, there is noteworthy activity today in ViewRay Inc , where a total volume of 6,309 contracts has been traded thus far today, a contract volume which is representative of approximately 630,900 underlying shares (given that every 1 contract represents 100 underlying shares). That number works out to 78.6% of VRAY's average daily trading volume over the past month, of 802,465 shares.

Leading Medical Physics Meeting To Feature More Than 40 Presentations On ViewRay's MRIdian MRI-Guided Radiotherapy

Leading Medical Physics Meeting To Feature More Than 40 Presentations On ViewRay's MRIdian MRI-Guided Radiotherapy

Presentations Highlight MRIdian Clinical Experience with Real-Time On-Table Adaptive Radiotherapy at a Growing Number of Institutions Worldwide

First Week Of July 19th Options Trading For ViewRay (VRAY)

First Week Of July 19th Options Trading For ViewRay (VRAY)

Investors in ViewRay Inc saw new options become available this week, for the July 19th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the VRAY options chain for the new July 19th contracts and identified one put and one call contract of particular interest.

World's First MRIdian Center Treats 1,000th Patient With MRI-Guided Radiation Therapy

World's First MRIdian Center Treats 1,000th Patient With MRI-Guided Radiation Therapy

Extensive Clinical Experience at Siteman Cancer Center Helps Further Adoption and Clinical Practice of MR-guided and On-Table Adaptive Radiation Therapy

ViewRay® To Present At The Jefferies 2019 Global Healthcare Conference

ViewRay® To Present At The Jefferies 2019 Global Healthcare Conference

CLEVELAND, May 16, 2019 /PRNewswire/ -- ViewRay, Inc. (NASDAQ: VRAY) today announced that the Company will participate in the Jefferies 2019 Global Healthcare Conference in New York, New York.

VRAY Crosses Above Key Moving Average Level

VRAY Crosses Above Key Moving Average Level

In trading on Wednesday, shares of ViewRay Inc crossed above their 200 day moving average of $8.22, changing hands as high as $8.44 per share. ViewRay Inc shares are currently trading up about 4.9% on the day.

Ratings Changes Today

TheStreet Quant Ratings provides fair and objective information to help you make educated investing decisions. We rate over 4,100 stocks daily and provide 5-page PDF reports for each stock. These ratings can change daily and today's changes are reflected in the email below. If you are looking to check-up on the stocks you currently own or are looking for new ideas, you can find our full database of password-protected ratings reports in our proprietary ratings screener: http://www.thestreet.com/k/qr/flat/stock-screener.html Upgrades: APO, CKH, CLCT, EARN, ERII, HCI, INN, KEN, LH, PBF, PPDF, PXLW, SHAK, TS Downgrades: D, EPAY, GSIT, HPP, REGI, RIVE, TDC, TYPE, VIRT, VRAY Initiations: None Read on to get TheStreet Quant Ratings' detailed report:

ViewRay Reports First Quarter 2019 Results

ViewRay Reports First Quarter 2019 Results

CLEVELAND, May 2, 2019 /PRNewswire/ -- ViewRay, Inc. (Nasdaq: VRAY) today announced financial results for the first quarter ended March 31, 2019.

ViewRay Enters Oversold Territory (VRAY)

ViewRay Enters Oversold Territory (VRAY)

Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index, or RSI, which measures momentum on a scale of zero to 100.

TheStreet Quant Rating: D- (Sell)